Streptokinase
- Generic Name
- Streptokinase
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9002-01-1
- Unique Ingredient Identifier
- 8X1OXL3SNU
- Background
Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.
- Indication
For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae
- Associated Conditions
- Acute Myocardial Infarction (AMI), Arterial Thromboembolism, Arterial thrombosis, Arteriovenous fistula occlusion, Arteriovenous fistula thrombosis, Arteriovenous occlusions, Central Retinal Vein Occlusion (CRVO), Chronic Occlusive Arterial Disease, Deep Vein Thrombosis, Peripheral artery thrombosis, Pulmonary Embolism, Pulmonary Embolism Acute Massive, Pulmonary Thromboembolism, Acute Arterial Thromboembolism
- Associated Therapies
- -
Intravenous Streptokinase in Acute Myocardial Infarction
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000507
Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
Phase 3
Completed
- Conditions
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath